Also trades as: SHIEF (OTC) · $vol 0M
STX.L LSE
Shield Therapeutics plc
1W: +14.4%
1M: +7.2%
3M: -2.5%
YTD: -44.6%
1Y: -26.5%
3Y: -43.3%
5Y: -86.5%
£6.00 ($0.08)
-0.05 (-0.83%)
Weekly Expected Move ±12.0%
£5
£5
£6
£7
£7
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$7M
+81.1% ▲
Capital Expenditures
$27K
+99.1% ▲
5Y CAGR: -54.4%
Free Cash Flow
-$7M
+82.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$5M
-150.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$20M | -$29M | -$33M | -$21M |
| Depreciation & Amort. | $4M | $2M | $2M | $1M | $1M |
| Stock-Based Comp. | $1M | $1M | $912K | $875K | $0 |
| Change in Working Capital | -$3M | -$2M | $3M | -$7M | $13M |
| Other Non-Cash Items | -$885K | -$572K | $4M | $1M | $567K |
| Operating Cash Flow | -$1M | -$17M | -$18M | -$37M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | -$23K | -$2M | -$2M | -$239K | -$2M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $3K | $13K | $200K | -$2M | $0 |
| Investing Cash Flow | -$20K | -$2M | -$2M | -$2M | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $9M | $24M | $4M |
| Stock Repurchased | $0 | $0 | -$82K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$55K | -$121K | -$1M | -$1M | -$167K |
| Financing Cash Flow | -$47K | $28M | $8M | $50M | $4M |
| Net Change in Cash | -$1M | $9M | -$9M | $11M | -$5M |
| Cash End of Period | $3M | $12M | $3M | $14M | $6M |
| Free Cash Flow | -$1M | -$19M | -$20M | -$40M | -$7M |